Cargando…
A 10-Long Non-Coding RNA-Based Expression Signature as a Potential Biomarker for Prognosis of Acute Myeloid Leukemia
BACKGROUND: Acute myeloid leukemia (AML) is a heterogeneous form of cancer, and it is one of the dominant causes of malignancy-related mortality in patients younger than 35 years old. Therefore, the treatment must be selected based on risk stratification. However, the methods to predict the clinical...
Autores principales: | Tang, Ping, Xie, Menghan, Wei, Yan, Xie, Xinsheng, Chen, Dandan, Jiang, Zhongxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636400/ https://www.ncbi.nlm.nih.gov/pubmed/31278736 http://dx.doi.org/10.12659/MSM.917182 |
Ejemplares similares
-
Long Non-Coding RNA ZFAS1 as a Novel Potential Biomarker for Predicting the Prognosis of Thyroid Cancer
por: Han, Chuan-Gang, et al.
Publicado: (2019) -
Establishment of the Prognosis Predicting Signature for Endometrial Cancer Patient
por: Tang, Jia, et al.
Publicado: (2019) -
Low Expression of Pseudogene POU5F1B Affects Diagnosis and Prognosis in Acute Myeloid Leukemia (AML)
por: Yi, Jing, et al.
Publicado: (2019) -
Long Non-Coding RNAs Serve as Diagnostic Biomarkers of Preeclampsia and Modulate Migration and Invasiveness of Trophoblast Cells
por: Luo, Xiucui, et al.
Publicado: (2018) -
Hypogelsolinemia in Patients Diagnosed with Acute Myeloid Leukemia at Initial Stage of Sepsis
por: Wątek, Marzena, et al.
Publicado: (2019)